These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report. Alabdulqader M; Alfakeeh K BMC Nephrol; 2021 Apr; 22(1):140. PubMed ID: 33879077 [TBL] [Abstract][Full Text] [Related]
3. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens. Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893 [TBL] [Abstract][Full Text] [Related]
4. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110 [TBL] [Abstract][Full Text] [Related]
5. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS. Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M Front Immunol; 2019; 10():853. PubMed ID: 31118930 [TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation. Okumi M; Tanabe K Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663 [TBL] [Abstract][Full Text] [Related]
7. Complement Genetic Variants and FH Desialylation in Gómez Delgado I; Corvillo F; Nozal P; Arjona E; Madrid Á; Melgosa M; Bravo J; Szilágyi Á; Csuka D; Veszeli N; Prohászka Z; Sánchez-Corral P Front Immunol; 2021; 12():641656. PubMed ID: 33777036 [TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registry. Soraru J; Isbel N; Wong G; Coates PT; Mantha M; Abraham A; Juneja R; Hsu D; Brown F; Bose B; Mudge D; Carroll R; Kausman J; Hughes P; Barbour T; Durkan A; Mount P; Lee D; Larkins N; Ranganathan D; Lim WH Nephrology (Carlton); 2020 Sep; 25(9):683-690. PubMed ID: 32378251 [TBL] [Abstract][Full Text] [Related]
9. Complement therapy in atypical haemolytic uraemic syndrome (aHUS). Wong EK; Goodship TH; Kavanagh D Mol Immunol; 2013 Dec; 56(3):199-212. PubMed ID: 23810412 [TBL] [Abstract][Full Text] [Related]
10. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report. Vondrák K; Seeman T Transplant Proc; 2018 Apr; 50(3):967-970. PubMed ID: 29661469 [TBL] [Abstract][Full Text] [Related]
11. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study. Wu D; Chen J; Ling C; Chen Z; Fan J; Sun Q; Meng Q; Liu X Nephron; 2021; 145(4):415-427. PubMed ID: 33873197 [TBL] [Abstract][Full Text] [Related]
12. Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007-2012. Åkesson A; Blom AM; Klintman J; Zetterberg E Nephrology (Carlton); 2017 Jul; 22(7):555-561. PubMed ID: 27175932 [TBL] [Abstract][Full Text] [Related]
13. An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab. Taton O; Delhaye M; Stordeur P; Goodship T; Le Moine A; Massart A Acta Gastroenterol Belg; 2016; 79(2):257-61. PubMed ID: 27382949 [TBL] [Abstract][Full Text] [Related]
14. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P Front Immunol; 2018; 9():848. PubMed ID: 29740447 [TBL] [Abstract][Full Text] [Related]
15. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome. Carter S; Hewitt I; Kausman J Nephrology (Carlton); 2017 Feb; 22 Suppl 1():7-10. PubMed ID: 28176479 [TBL] [Abstract][Full Text] [Related]
16. Copy number variation analysis using next-generation sequencing identifies the Park J; Yhim HY; Kang KP; Bae TW; Cho YG Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302 [TBL] [Abstract][Full Text] [Related]
17. Various phenotypes of disease associated with mutated DGKE gene. Bezdíčka M; Pavlíček P; Bláhová K; Háček J; Zieg J Eur J Med Genet; 2020 Aug; 63(8):103953. PubMed ID: 32413569 [TBL] [Abstract][Full Text] [Related]
18. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome. Raina R; Mangat G; Hong G; Shah R; Nair N; Abboud B; Bagga S; Sethi SK Front Immunol; 2022; 13():931210. PubMed ID: 36091034 [TBL] [Abstract][Full Text] [Related]
19. Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients. Terano C; Ishikura K; Hamada R; Yoshida Y; Kubota W; Okuda Y; Shinozuka S; Harada R; Iyoda S; Fujimura Y; Hamasaki Y; Hataya H; Honda M Nephrology (Carlton); 2018 Jun; 23(6):539-545. PubMed ID: 28387984 [TBL] [Abstract][Full Text] [Related]